Official UK procurement notice
iLab Telepath Support and Disaster Recovery
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)
What is being bought
Published requirement descriptionDedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
CPV: Medical software package · System maintenance services
The lotProcurement structure
single lot · no lot value publishedLot #1The proposed contract with Dedalus for ilab Telepath support and disaster recovery is…Awarded
The proposed contract with Dedalus for ilab Telepath support and disaster recovery is to ensure the service continuity for critical Transfusion delivery. Dedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- as per procurement docs: 100%
Published award criteria (2)
- as per procurement docs: 100
- Price: 0
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Cancelled
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 18 Nov 2021, 12:04 GMT
- Last source update
- 12 Aug 2022, 15:35 BST
- FTS notice number
2022/S 000-022324- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02f7ebFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The proposed contract with Dedalus for ilab Telepath support and disaster recovery is to ensure the service continuity for critical Transfusion delivery. Dedalus are the current incumbent supplier for Telepath, and the system hosts a vast archive of historical data which is used to assess cross matching compatibility. Transfusion throughout Wales has not moved to the national system (WLIMS) but is scheduled to do so under the new LINC arrangements. This is anticipated to commence 2024 in BCUHB subject to suitable verification and validation of performance, and hence a full cover period is required from 2021-2025. Therefore the only viable option is to retain the existing services and vital cover via a direct award process for service continuity, in order to ensure patient safety and ability to handle blood products in accordance with legislative requirements and national guidelines. Failure to award to the incumbent supplier will result in cessation of transfusion services with an impact to AE, Theatres, Maternity, cancer services and critical care services.
Publisher note: (WA Ref:123992)
Notice history
1 event · 2 releases on Find a Tender- Status changed to cancelled12 Aug 2022, 15:35 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| DH OpCo UK Ltd (Dedalus) | £486,551 † | — | Awarded |
1 further award records carry no date or value.
Contracts
Contract 028796-2021-1 · DH OpCo UK Ltd (Dedalus)
- Signed
- 10 Nov 2021
- Value
- £486,551
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- DH OpCo UK Ltd (Dedalus)Awarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.